Progress toward virtual screening for drug side effects.

Area of Science:

• Computational chemistry
• Pharmacology
• Drug discovery

Background:

• Virtual screening is crucial for identifying drug-target interactions.
• Accurate prediction of drug side effects is essential for safe and effective therapeutics.
• Computational docking algorithms offer a promising approach for in silico drug screening.

Purpose of the Study:

• To develop and validate a computational protocol for virtual screening of drug side interactions.
• To assess the efficacy of a drug-docking algorithm in identifying specific receptor-ligand interactions.
• To evaluate the use of homology-modeled protein structures in drug-target interaction studies.

Main Methods:

• Utilized AutoDock, a conventional drug-docking algorithm, for virtual screening.
• Performed docking simulations using guanosine diphosphate and adenosine diphosphate to differentiate known receptors.
• Investigated the binding of clinically relevant inhibitors (Gleevec, purvalanol A, hymenialdisine) to protein kinase targets.

Main Results:

• Achieved 100% specificity and 94% sensitivity in identifying receptors using electrostatic energy of the purine ring.
• Demonstrated excellent agreement between predicted and experimental preferences for kinase targets.
• Validated the use of homology-modeled protein structures as viable targets for docking simulations.

Conclusions:

• The developed computational protocol effectively screens for drug side interactions.
• Electrostatic properties of the purine ring are reliable indicators for receptor discrimination.
• Homology-modeled structures can be reliably used in docking studies when crystal structures are unavailable, advancing drug discovery efforts.